Physician

Thaila Ramanujam, MD

According to 2025 Medicare claims, Thaila Ramanujam, MD (NPI: 1801999206) practices rheumatology in the Santa Cruz-Watsonville, CA market, with the plurality of this provider's patient population coming from Santa Cruz, CA. This provider's primary affiliated billing organization is THAILA RAMANUJAM M D INC (NPI: 1700056280; TIN: 26-1825888) and primary practice location at 95065-1716.

Ramanujam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 688 traditional Medicare patients, billed 423,682 HCPCS/CPT codes, and received $4,139,617 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,410 prescription claims across 215 beneficiaries totaling $960,782 in drug costs, led by Rinvoq (Upadacitinib). Open Payments data shows 146 records totaling $30,132. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $755,691 to $4,139,617. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.1M$4.1M2015 Medicare payment: $755,691 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,087,444 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,583,678 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,717,995 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,949,210 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,662,636 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,857,290 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,267,616 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,187,046 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,139,617 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201535526,887$755,691
201636532,702$1,087,444
201739054,577$1,583,678
201841675,566$1,717,995
201946881,627$1,949,210
2020361165,613$2,662,636
2021420214,970$2,857,290
2022333174,949$2,267,616
2023312201,888$2,187,046
2024688423,682$4,139,617

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$972K$1.9M2015 Drug cost: $1,286,908 (USD; Tot_Drug_Cst)2016 Drug cost: $1,943,499 (USD; Tot_Drug_Cst)2017 Drug cost: $1,501,910 (USD; Tot_Drug_Cst)2018 Drug cost: $1,485,704 (USD; Tot_Drug_Cst)2019 Drug cost: $1,119,256 (USD; Tot_Drug_Cst)2020 Drug cost: $1,026,635 (USD; Tot_Drug_Cst)2021 Drug cost: $1,149,562 (USD; Tot_Drug_Cst)2022 Drug cost: $1,221,297 (USD; Tot_Drug_Cst)2023 Drug cost: $1,378,932 (USD; Tot_Drug_Cst)2024 Drug cost: $960,782 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152571,903$1,286,908
20162711,940$1,943,499
20172681,643$1,501,910
20182611,459$1,485,704
20192701,583$1,119,256
20202581,380$1,026,635
20213001,562$1,149,562
20222631,434$1,221,297
20232401,641$1,378,932
20242151,410$960,782

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less184890$122
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more248702$105
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less137324$58
96372Injection of drug or substance under skin or into muscle284579$13
J1306Injection, inclisiran, 1 mg15458,788$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RinvoqUpadacitinib351,050$222,310
Humira(Cf) PenAdalimumab23644$153,122
Cosentyx Sensoready (2 Pens)Secukinumab13364$96,414
Enbrel SureclickEtanercept13364$91,074
Xeljanz XrTofacitinib Citrate12360$68,293

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.146$30,132Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Thaila Ramanujam, MD?

Tedicare shows public-source Medicare data for Thaila Ramanujam, MD (NPI 1801999206), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thaila Ramanujam, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Thaila Ramanujam, MD?

Thaila Ramanujam, MD is linked to THAILA RAMANUJAM M D INC (billing NPI 1700056280) in the available physician profile data.

Does Thaila Ramanujam, MD have Open Payments data?

Thaila Ramanujam, MD has 146 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.